Total Payments
$6,828
2024 Payments
$818.62
Companies
26
Transactions
114
Medicare Patients
1,775
Medicare Billing
$248,139
Payment Breakdown by Category
Food & Beverage$6,800 (99.6%)
Other$28.57 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,800 | 113 | 99.6% |
| Grant | $28.57 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,170 | 27 | $0 (2024) |
| ABBVIE INC. | $995.89 | 19 | $0 (2024) |
| Cook Medical LLC | $751.76 | 18 | $0 (2023) |
| Covidien LP | $433.66 | 5 | $0 (2020) |
| Celgene Corporation | $415.24 | 1 | $0 (2024) |
| Ambu Inc. | $220.99 | 2 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $205.49 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $186.57 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $157.17 | 9 | $0 (2024) |
| STERIS Corporation | $142.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $818.62 | 18 | Celgene Corporation ($415.24) |
| 2023 | $869.11 | 17 | AbbVie Inc. ($381.00) |
| 2022 | $523.10 | 8 | ABBVIE INC. ($174.79) |
| 2021 | $795.62 | 8 | Boston Scientific Corporation ($515.93) |
| 2020 | $714.39 | 9 | Boston Scientific Corporation ($406.09) |
| 2019 | $1,530 | 28 | Boston Scientific Corporation ($424.81) |
| 2018 | $667.97 | 13 | BOSTON SCIENTIFIC CORPORATION ($210.01) |
| 2017 | $909.27 | 13 | Covidien LP ($305.79) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/01/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Immunology | ||||||
| 04/11/2024 | Boston Scientific Corporation | APOLLO ESG System (Device) | Food and Beverage | In-kind items and services | $93.38 | General |
| Category: APOLLO ESG System_ENDO | ||||||
| 03/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Immunology | ||||||
| 03/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $415.24 | General |
| Category: Neuroscience | ||||||
| 02/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: Immunology | ||||||
| 02/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/27/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | AbbVie Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Immunology | ||||||
| 10/11/2023 | Boston Scientific Corporation | SpyGlass Discover (Device) | Food and Beverage | In-kind items and services | $94.20 | General |
| Category: SpyGlass Discover_ENDO | ||||||
| 09/19/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 424 | 426 | $495,984 | $63,714 |
| 2022 | 8 | 430 | 435 | $397,472 | $59,575 |
| 2021 | 10 | 515 | 524 | $399,783 | $73,218 |
| 2020 | 11 | 406 | 413 | $265,048 | $51,632 |
Total Patients
1,775
Total Services
1,798
Medicare Billing
$248,139
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 116 | 116 | $184,305 | $23,406 | 12.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 66 | 66 | $66,362 | $12,047 | 18.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 73 | 73 | $97,871 | $9,447 | 9.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 34 | 34 | $34,532 | $6,217 | 18.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 73 | $64,330 | $5,842 | 9.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $23,234 | $3,085 | 13.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $23,888 | $2,820 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $1,462 | $850.51 | 58.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 96 | 96 | $123,509 | $19,280 | 15.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 79 | 80 | $84,875 | $9,442 | 11.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 45 | 45 | $38,673 | $8,337 | 21.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 50 | 50 | $43,460 | $7,034 | 16.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 79 | $56,129 | $6,204 | 11.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 49 | $30,259 | $4,195 | 13.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 22 | 22 | $18,330 | $4,030 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $2,237 | $1,053 | 47.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 116 | 116 | $130,948 | $24,134 | 18.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 56 | 56 | $40,264 | $10,587 | 26.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 82 | 82 | $78,340 | $10,470 | 13.4% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 59 | 59 | $46,947 | $8,419 | 17.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 78 | 80 | $50,160 | $7,198 | 14.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 25 | 25 | $17,831 | $4,820 | 27.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 48 | 48 | $25,542 | $4,150 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 28 | $5,183 | $1,750 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 17 | $2,311 | $925.63 | 40.1% |
About Dr. Mark Silversmith, M.D
Dr. Mark Silversmith, M.D is a Gastroenterology healthcare provider based in Bedford, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104825587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Silversmith, M.D has received a total of $6,828 in payments from pharmaceutical and medical device companies, with $818.62 received in 2024. These payments were reported across 114 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,800).
As a Medicare-enrolled provider, Silversmith has provided services to 1,775 Medicare beneficiaries, totaling 1,798 services with total Medicare billing of $248,139. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bedford, NH
- Active Since 07/19/2005
- Last Updated 09/20/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104825587
Products in Payments
- RESOLUTION CLIP (Device) $572.12
- ZEPOSIA (Drug) $415.24
- RINVOQ (Biological) $370.85
- DUPIXENT (Biological) $267.73
- DREAMTOME (Device) $262.36
- PillCam (Device) $251.54
- Humira (Biological) $205.16
- SKYRIZI (Biological) $181.45
- STELARA (Biological) $177.11
- TruFreeze (Device) $142.83
- Instinct (Device) $136.86
- GENERAL BILIARY DEVICES (Device) $133.62
- GATTEX (Drug) $132.21
- Cook Medical (Device) $125.26
- C2 CryoBalloon (Device) $125.17
- Cook Medical Metal Stents - Non-Biliary (Device) $123.91
- EXALT (Device) $122.63
- CAPTIVATOR COLD (Device) $116.48
- OCALIVA (Drug) $116.37
- ESOPHYX (Device) $112.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bedford
Dr. Jay Yepuri, M.d, M.D
Gastroenterology — Payments: $402,569
Gastroenterology $402,569
Jessica Shah, Md, MD
Gastroenterology — Payments: $58,361
Gastroenterology $58,361
Dr. David Hall, M.d, M.D
Gastroenterology — Payments: $9,026
Gastroenterology $9,026
Dr. Thomas Lyles, M.d, M.D
Gastroenterology — Payments: $9,021
Gastroenterology $9,021
Dr. Andrew Shea, M.d, M.D
Gastroenterology — Payments: $8,332
Gastroenterology $8,332
Dr. Bhavin Patel, M.d, M.D
Gastroenterology — Payments: $7,659
Gastroenterology $7,659